Dr. Dougherty is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Road NW
Washington, DC 20007
Summary
- Dr. Carrie Dougherty is a neurologist based in Mc Lean, VA, specializing in headache disorders. She completed her internship in Internal Medicine at McGaw Medical Center, Northwestern University, and residency in Neurology at MedStar Health/Georgetown University Hospital. She has in-depth experience in headache medicine, botulinum toxin injections for headache and has substantial contributions to the field through her publications in reputable journals, chiefly in 'Headache' and 'Current Pain and Headache Reports'. Topics of her research include evaluation of vascular risk in migraine patients, Raynaud's phenomenon, dermatologic symptoms associated with headache, and medication dosage reviews for migraine prevention.
Education & Training
- MedStar Health/Georgetown University HospitalResidency, Neurology, 2009 - 2012
- McGaw Medical Center of Northwestern UniversityInternship, Internal Medicine, 2008 - 2009
- Indiana University School of MedicineClass of 2008
Certifications & Licensure
- VA State Medical License 2012 - 2026
- DC State Medical License 2009 - 2024
- MD State Medical License 2012 - 2024
- PA State Medical License 2012 - 2014
- IL State Medical License 2008 - 2009
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 4 citationsErenumab dosage for migraine prevention: An evidence-based narrative review with recommendations.Stewart J Tepper, Huma U Sheikh, Carrie O Dougherty, Stephanie J Nahas, Paul K Winner
Headache. 2022-04-01 - 12 citationsClinical Presentation and Management of Headache in Pituitary Tumors.Himanshu Suri, Carrie Dougherty
Current Pain and Headache Reports. 2018-06-15 - The 2024 Scottsdale Headache Symposium: A banner year.Deborah I Friedman, Carrie Dougherty, Scott W Powers
Headache. 2024-10-17
Press Mentions
- Updated STOP 301 Results Demonstrate Safety, Tolerability of INP104 for MigraineJune 4th, 2021
- Impel Neuropharma to Present Pivotal, Phase 3 Data from STOP-301 Study at the 63rd Annual Meeting of the American Headache SocietyJune 2nd, 2021
- Migraine World Summit Premieres Online March 17th - 25th, 2021February 8th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: